H 945 (see companion bill S 749) – Massachusetts
Introduced: 2023 Status: In Process
An Act to ensure prescription drug cost transparency and affordability
Haw. Rev. Stat. §§ 328-91 through 328-106: Drug Product Selection – Hawaii
Status: Enacted Year Enacted: 1980
A pharmacy benefit manager that reimburses a contracting pharmacy for a drug on a maximum allowable cost basis shall comply with the requirements of this section. (b) The pharmacy benefit manager shall include the following …
Download
Haw. Rev. Stat. §§ 346-51 through 346-70: Specific Provisions Covering Public Assistance and Child Welfare Services – Hawaii
Status: Enacted Year Enacted: 1998
The State’s Medicaid managed care and fee-for-service programs shall not deny coverage for any service provided through telehealth that would be covered if the service were provided through in-person consultation between a patient and a …
Download
HB 1033 – North Dakota
Introduced: 2021 Status: Enacted
AN ACT to amend and reenact section 19‑02.1‑14.3 of the North Dakota Century Code, relating to prescribing of biosimilar drugs, requires a pharmacist or a pharmacist’s designee to notify the prescribing practitioner of a substitution …
HB 1119 – Maryland
Introduced: 2020 Status: Inactive / Dead
Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product. Requiring a pharmacist, or the pharmacist’s designee who is under certain supervision, to inform a certain consumer of the availability of certain …
HB 114 (see companion bill SB 45) – Kentucky
Introduced: 2021 Status: Inactive / Dead
Amend KRS 304.17A-164 to redefine “cost-sharing” and define “generic alternative,” “health plan,” “insured,” and “person”; prohibit an insurer or pharmacy benefit manager from excluding any cost-sharing amount paid by or or behalf of an insured …
HB 1269 – Arkansas
Introduced: 2019 Status: Enacted
To Allow Pharmacists To Make Biological Product Substitutions.
HB 1280 – New Hampshire
Introduced: 2019 Status: Enacted
Relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative …
HB 1356 – Washington
Introduced: 2023 Status: In Process
AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines
HB 137 – Mississippi
Introduced: 2018 Status: Inactive / Dead
PROHIBITION ON PRICE GOUGING FOR ESSENTIAL DRUGS ACT. Prohibits manufacturers and wholesale distributors of essential generic drugs from engaging in price gouging. This bill requires the division of Medicaid and Department of Human Services to …
HB 156 – Illinois
Introduced: 2019 Status: Enacted
BIOLOGICAL PRODUCTS-DRUG PRICE. Creates the Prescription Drug Pricing Transparency Act. Requires health insurers to disclose certain rate and spending information concerning prescription drugs and certain prescription drug pricing information to the Department of Public Health. Requires …
HB 1562 (see companion bill SB 5601) – Washington
Introduced: 2019 Status: Inactive / Dead
CONCERNING HEALTH CARE BENEFIT MANAGEMENT. A health care benefit manager doing business as a pharmacy may not place a drug on a list unless there are at least two therapeutically equivalent multiple source drugs, or …
HB 1725 – Washington
Introduced: 2023 Status: In Process
Increasing access to insulin for individuals under the age of 21. The Health Care Authority (HCA) is directed to establish a bulk purchasing and distribution program for insulin for individuals under the age of 21 …
HB 1780 – New Hampshire
Introduced: 2017 Status: Inactive / Dead
PROHIBITING PRICE GOUGING BY CERTAIN PRESCRIPTION DRUG COMPANIES: This bill would prohibit price gouging of essential off-patent or generic drugs. The Department of Justice would be charged with enforcing the statute. To determine whether a …
HB 1791 – New Hampshire
Introduced: 2018 Status: Enacted
Would allowing pharmacists to disclose information relative to lower cost drugs. Would prevent contracts between an insurance carrier or pharmacy benefit manager and a contracted pharmacy fromcontaining a provision prohibiting divulgence to a covered person …
HB 195 – Montana
Introduced: 2017 Status: Inactive / Dead
REVISE LAWS RELATED TO PHARMACIES AND PRESCRIPTION DRUGS: Allows pharmacists who receive a prescription for a specific drug product by brand or proprietary name may select a less expensive drug product with the same name, …